The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
Clinical trial NCT03562169 · RECRUITING
Trial details
- NCT number
- NCT03562169
- Sponsor
- University of Leeds
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-20
- Primary completion
- 2026-03-01
- Enrollment
- 406
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.